MedPath

The Effect of Increased Water Intake on the Frequency of the Clinical Recurrent Urinary Tract Infections in Pre-menopausal Women: S-HYDRACYST

Not Applicable
Completed
Conditions
Recurrent Urinary Tract Infection
Registration Number
NCT02444975
Lead Sponsor
Danone Research
Brief Summary

The purpose of this study is to determine whether increased water intake is effective in preventing episodes of uncomplicated urinary tract infections (UTI) in pre-menopausal women suffering from UTI recurrences.

Detailed Description

This study aims to assess the effect of increased daily water intake on the frequency of clinical, recurrent urinary tract infections (UTI) among low drinking pre-menopausal women suffering from recurrent community-acquired UTI over 12 consecutive months of study product consumption. It is a prospective, single site, open-label, randomised controlled trial in two parallel groups:

* Control group: not changing their fluid intake habits

* Intervention group: provided with mineral water, fluid intake recommendations and regular hydration coaching support

The study population consists in pre-menopausal women diagnosed with recurrent UTIs and having a 'low drinker' profile.

The total number of randomized subjects in this study is estimated at 140. The study will include only women who are low-drinkers (\< 1.5 L fluids per day; urinary volume \< 1.2 L per day) since they are most likely to have a predisposition to UTIs due to infrequent voiding.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
140
Inclusion Criteria
  • At least 3 clinical recurrences of symptomatic UTI in the last 12 months
  • Age ≥ 18 years
Exclusion Criteria
  • Incapacity / non-willingness to consume 1.5 L of drinking water per day on top of their usual consumption
  • Women with history of UTI complications (pyelonephritis or other) in the last 12 months
  • Subjects with interstitial cystitis
  • Subjects with severe or uncontrolled organic disease, likely to interfere with the parameters of the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Incidence of UTI12 months

Difference between groups in term of UTI recurrence over 12 months of study intervention

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mc "Comac Medical"

🇧🇬

Sofia, Bulgaria

Mc "Comac Medical"
🇧🇬Sofia, Bulgaria
© Copyright 2025. All Rights Reserved by MedPath